Added corticosteroid deemed ineffective for cancer pain

July 16, 2014
Added corticosteroid deemed ineffective for cancer pain

(HealthDay)—The addition of methylprednisolone (MP) to opioid therapy does not appear to increase the analgesic effect for cancer pain, according to research published online July 7 in the Journal of Clinical Oncology.

Ørnulf Paulsen, M.D., of the Telemark Hospital Trust in Skien, Norway, and colleagues randomly assigned 50 adult patients receiving opioids for cancer pain to either with MP or placebo (PL).

At day seven, the researchers observed no difference between the groups in pain intensity (MP, 3.60 versus PL, 3.68; P = 0.88) or relative analgesic consumption (MP, 1.19 versus PL, 1.20; P = 0.95). Patients receiving MP, compared with those receiving PL, experienced reduced fatigue (−17 versus 3 points; P = 0.003), decreased appetite loss (−24 versus 2 points; P = 0.003), and increased (5.4 versus 2.0 points; P = 0.001). No differences in adverse effects were observed between the groups.

"MP 32 mg daily did not provide additional analgesia in patients with cancer receiving opioids, but it improved fatigue, appetite loss, and patient satisfaction," the authors write. "Clinical benefit beyond a short-term effect must be examined in a future study."

Explore further: Chiropractic care beats sham therapy for spinal pain

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Chiropractic care beats sham therapy for spinal pain

November 19, 2013
(HealthDay)—Short-term chiropractic therapy is more effective than a sham intervention for treating spinal pain, but the difference is not clinically meaningful, according to research published in the Nov. 15 issue of Spine.

Drinking coffee, smoking may protect against cholangitis

July 8, 2014
(HealthDay)—Coffee consumption and smoking might protect against the development of primary sclerosing cholangitis (PSC), according to a study published in the June issue of Clinical Gastroenterology and Hepatology.

Screening tool does not cut distress in cancer patients

September 7, 2013
(HealthDay)—Distress monitoring and needs assessment using the Distress Thermometer and Problem List (DT&PL) does not appear to be cost-effective in improving mood states in cancer patients, according to research published ...

Beta-blockers have no impact on cocaine-related chest pain

June 3, 2014
(HealthDay)—For patients with cocaine-associated chest pain, there are no differences in outcome for those treated with or without β-blockers, according to a study published in the June 1 issue of The American Journal ...

Multimodal analgesia lessens post-op morphine needs

August 23, 2013
(HealthDay)—A multimodal analgesia combination appears to be safe and effective for pain relief after lumbar decompressive laminectomy, according to a study published in the August issue of the Journal of Spinal Disorders ...

Evidence lacking for long-term opioid use in low back pain

April 16, 2014
(HealthDay)—There is evidence of short-term efficacy (moderate for pain and small for function) of opioids for treatment of chronic low back pain (CLBP) compared with placebo; however, the effectiveness and safety of long-term ...

Recommended for you

Targeted antibiotic use may help cure chronic myeloid leukaemia

September 19, 2017
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.

Researchers compose guidelines for handling CAR T cell side effects

September 19, 2017
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists, one addressed by a team led by clinicians at The University ...

Brain powered: Increased physical activity among breast cancer survivors boosts cognition

September 19, 2017
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help. In ...

Bone marrow protein a 'magnet' for passing prostate cancer cells

September 19, 2017
Scientists at the University of York have shown that a protein in the bone marrow acts like a 'magnetic docking station' for prostate cancer cells, helping them grow and spread outside of the prostate.

Brain cancer breakthrough could provide better treatment

September 19, 2017
A new discovery about the most common type of childhood brain cancer could transform treatment for young patients by enabling doctors to give the most effective therapies.

A new paradigm for treating transcription factor-driven cancers

September 18, 2017
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.